Company · CIK 0001790340 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Immuneering Corp · IMRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 AForm 4 → | Jul 17, 4:29 pm EDT | Andrew GengosChief Financial Officer | 650,000 | — | — | 650,000 | — |